Latest Sirtuin Stories
U.S. researchers have found cocaine regulated molecular pathways that may lead to addiction treatments. The study, published in Cell Press, finds long-lasting changes in behavior are elicited as cocaine regulates gene expression in a crucial reward region of the brain.
New research sheds light on how cocaine regulates gene expression in a crucial reward region of the brain to elicit long-lasting changes in behavior. The study, published by Cell Press in the May 14th issue of the journal Neuron, provides exciting insight into the molecular pathways regulated by cocaine and may lead to new strategies for battling drug addiction.
SAN DIMAS, Calif., March 10 /PRNewswire/ -- A recent CBS 60 Minutes TV program drew considerable attention to resveratrol (rez-vair-ah-trawl), a red wine molecule believed to largely be responsible for the French Paradox, the fact the French have far more people living beyond 100 years and exhibit a far lower mortality rate from heart disease than other people living in other developed countries, despite the high-calorie, high-fat diet in France. (Photo:...
TORONTO, Feb. 27 /PRNewswire/ -- The following was written by W. Gifford-Jones M.D., a medical journalist. How do the French differ from North Americans? They eat fat-rich, calorie-packed baked goodies which are not heart healthy.
SAN DIMAS, Calif., Jan.
SAN DIMAS, Calif., Dec.
Harvard researchers report finding a new clue into the reason for aging in a minor ingredient of red wine and its role in activating a protein. Scientists said they made their finding while trying to understand how the agent resveratrol improves the health and lifespan of laboratory mice, The New York Times reported.
RevGenetics (http://www.revgenetics.com/), at the forefront of developing uncommonly effective products using common herbal ingredients, unveils Sirtuin Skin, a resveratrol powered skin care cream.
Research and Markets (http://www.researchandmarkets.com/research/736e52/molecular_biology) has announced the addition of the "Molecular Biology of Aging" report to their offering.
Sirtris, a GSK company focused on discovering and developing small molecule drugs to treat diseases of aging such as Type 2 Diabetes, today announced that it will provide an update on the Company's clinical and preclinical progress at the 2008 Boston Biotech R&D Conference on Wednesday, October 22, 2008 at Harvard Medical School.
- A trick or prank.